Transforming Growth Factor – Bench To Bedside. Towards a better understanding of TGF-β isoform specific signalling in health and disease

Project Information

TGF-BTB

Grant agreement ID: 893196

DOI

10.3030/893196

Project closed

EC signature date 4 March 2020

Start date 1 June 2020

End date 31 July 2023

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 271 732,80

EU contribution

€ 271 732,80

Coordinated by

UNIVERSITY OF LEEDS
United Kingdom

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Novel TGFβ Inhibitors Ameliorate Oral Squamous Cell Carcinoma Progression and Improve the Antitumor Immune Response of Anti-PD-L1 Immunotherapy.

Author(s): Nils Ludwig; Łukasz Wieteska; Cynthia S. Hinck; Saigopalakrishna S. Yerneni; Juliana Hofstatter Azambuja; Richard Bauer; Torsten E. Reichert; Andrew P. Hinck; Theresa L. Whiteside
Published in: Mol Cancer Ther, Issue 1, 2021, ISSN 1535-7163
Publisher: American Association for Cancer Research
DOI: 10.1158/1535-7163.mct-20-0944